2001
DOI: 10.1023/a:1011048905732
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2001
2001
2007
2007

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…21) Without IND, ADM or CDDP, the tumor cells were rejected by the mice that were reinoculated with tumor cells (Table 1). Antitumor immunity was also observed against MCP-1 transfectant when ADM, BLM or CDDP was administered in combination with IND.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…21) Without IND, ADM or CDDP, the tumor cells were rejected by the mice that were reinoculated with tumor cells (Table 1). Antitumor immunity was also observed against MCP-1 transfectant when ADM, BLM or CDDP was administered in combination with IND.…”
Section: Resultsmentioning
confidence: 99%
“…[18][19][20] We have shown that IND and bleomycin (BLM) exhibit a strong synergistic effect. 21) In this report, we carried out further investigations of a combination of IND with adriamycin (ADM) or cisplatin (CDDP), which have different potencies and sites of action compared with BLM.…”
Section: )mentioning
confidence: 99%
See 1 more Smart Citation